acute respiratory ok

Upload: dwi-sastrawan

Post on 10-Jan-2016

218 views

Category:

Documents


0 download

DESCRIPTION

ok

TRANSCRIPT

  • ACUTE RESPIRATORY DISTRESS SYNDROME[ ARDS ]

    by: Anastasia D.H.

  • DEFINITION: syndrome signed by: - increase of permeability alveolo capilair membrane against water, solution & plasma protein. - diffuse alveolar disturbance. - fluid accumulation inside lung parenchym consist of protein.

  • Based Definition by American-Europe ARDS Coference Committee 1994: 1. Respiratory failure/distress acute onset 2. Ratio of artery vessel oxygen pressure with inspiration oxygen fraction (PaO2/ Fi O2) < 200 mmHg Hipoksemia berat. 3. Chest Radiography: bilateral alveolar infiltrat represent Lung edema 4. Pulmonary capillary wedge pressure
  • If PaO2/Fi O2 200-300 mmHg---Acute Lung Injury, corelation of risk factor ALI with absence Chronic Lung disease.

    RISK FACTORS Direct injury alveolus epithel:Aspiration of gaster contentDiffuse lung infectionLung contusioDrownningToxic inhalation

  • Indirect injury: 1. Septic 2. Non thoraxic trauma 3. Overload blood tranfussion 4. Pankreatitis 5. Cardiopulmonarry shunt

    PATOPHYSIOLOGYBegin with alveolar epithel & microvascular dis-turbance, caused by direct/indirect injury, thenactivate cascade inflamation, divided 3 phase:

  • 1.Initiation phase : risk factor condition cause imune & non imune cells relieves inflamatory mediators & modulators inside lung towards systemic

    2.Amplification phase : efector cell/netrofil is activated,pull & persisted inside lung.

    3.Injury phase : inside target organ, relieves inflamatory mediator include oxydase & protease, directly destroy the lung & stimulate next inflamatory process.Membran alveolo-capilair damage cause increase membrane permeability & flow of rich protein liquid enter alveolar space then disturb surfactan integrity cause further alveolair disturbance

  • 3 Phase Alveolar DisturbanceExudative phase: interstitial & alveolar edema, pneumosit cell necrose & denudation basal membrane, endothel cell swelling with intercelluler junction widening, hyalin membrane formed in alveolar duct & air space, netrofil inflamation,also found pulmoner hypertension & decrease of lung compliance.Proliferative phase: fastest happened after 3 days onset, sign: pneumocyte epithel cel proliferation.Fibrotic phase: colagen increased, lung become solid caused of fibrotic

  • CLINICAL MANIFESTATIONSGenerally,acute onset 3 5 days since conditionas ARDS risk factor is diagnosed. First sign: tachypnea Others: hypotension, feverAuscultation: wet ronkhiDIAGNOSTIC EVALUATIONLaboratory Findings:1. Blood Gas Analyzes: hypoxemia, hypocapnea (secondary cause of hyperventilation), hypercapnea (in emphysema or further condition).

  • Alkalosis Respiratory in beginning process replace to Acidosis Respiratory. 2. Leucocytosis (on septic), anemia, trombosito-penia (systemic inflamatory reflection & endothelial injury), increased of amylase level (on pancreatitis)3. Renal & Liver function disturbances, dissemi-nated intravasculer coagulation (as part of MDS /multiple organ dysfunction syndrome)

    Imaging:Chest X-Ray: beginning process found lung area relatively clear,then diffuse radioopaque shadow seen & no gravitation influence, without heart congestion descriptionCT scan: heterogenous pattern, infiltrat predomination on dorsal lung area (supine photo)

  • DIFFERENTIAL DIAGNOSTIC:Cardiogenic, Neurogenic lung edemaLung infection: (V,B,F)High Altitude Pulmonarry Edema (HAPE)Laryngospasm induce lung edemaDrug induce lung edema (heroin, salicylate, cocain)Radiation, Hypersensitivity PneumonitisFat embolic syndromeMitral stenosis with alveolar bleedingVasculitisInterstitial lung disease

  • MANAGEMENT1. Take over respiratory function with mechanical ventilator2. Agent therapy: - Corticosteroid on ARDS/ALI advanced phase or fibroploriferative phase.(severe persistent hypoxemia in the seventh day ARDS) - Nitric Oxide inhalation (NO) give selective vasodilatation effect on distribution lung area caused decreased pulmonarry artery,repair arterial oxyganation.Only give for refracter severe hypoxia.3. Patient position: prone position increased oxygenation but not change mortality

  • 4. Fluid: must balance between - needs of optimal organ perfussion - fluid extravasation problem to lung & tissue: increase of intravascular hydrostatic pressure caused fluid accumulation in alveolus.Main focus: defence adequate perfussion without oxygenation victimize.Fluid restriction, best monitor by pulmonary arte-ry catheterization, defence in level: lowest intra vascular hydrostatic pressure, but adequat cardiac output

  • COMPLICATION: -- MODS, nosocomial pneumonia, barotrauma, pneumotorax, trakeomalasia, trakeoesofageal fistule, inominata artery errosion, death.

    PROGNOSE: mortality : 40 % affected by:--Risk factors (septic,post trauma,etc), main disease, malignancy, presence MODS ,age, alcoholism, presence gas exchange index recovery (Pa O2/FiO2) in 3 7 day.-- good response: lung function recovery in 3 months, max. 6 months post extubation.-- 50 % patient abnormality persistent, restriction disturbance & decrease difusion capacity--- decrease quality of life

  • MUTIPLE ORGAN FAILUREPASCA TRAUMADEFINITION MOF : found 2 / > organ / system failure1. Cardiovasculair failure: - HR 54/minute, MAP 49 mmHg, VT & orVF, pH serum 7,24 dg. PCO2 40 mmHg.2. Respiratory failure: - RR 5/min,or 49/min, PaCO2 50 mmHg, on ventilator in 4th day 3. Renal failure: diuresis 479 ml/24 h or 159 ml/8h, BUN 100 mg/dl, creatinin serum 3,5 mg/dl

  • 4. Hepatic failure: bilirubin serum 6mg/dl, PT > 4 sec (without anticoagulant)5. Central Nervous Systemic failure: GCS 6 (without sedative)6. Hematological failure: Leuc 1000/ml, Tr 20.000/ml, Ht 20%7. Coagulation system failure: trombocytopenia, PT& APTT,BT memanjang, Hypofibrinogenemia8. ARDS : history disease, PaO2 / FIO2 < 200 mmHg, diffuse infiltrat on X-Ray, no pulmonary infection, low pulmonary compliance, Pulmonary capillary wedge pressure < 18 mmHg.

  • 9. Acute Lung Injury: PaO2 / FIO2 < 300 mmHg, + ARDS criteria

    ETIOLOGY: trauma: multiple trauma, post operation, visceral ischemia, epileptic status, heat injury, abdominal compartemen syndr

  • PATOGENESIS - cause of local insult or infection, pro inflamato- ry mediators released against foreign antigenes to relieve the wound. - then followed by anti inflamatory mediators released to regulate this process,homeostasis reached,patient recovered. - if there is severe pathologic insult, local defence mechanism doesnt success, inflamatory mediators will enter to systemic sirculation & new leucocyts recruit in inflamatory area. Stress respon happen in the whole body. Ones more, anti inflamatory mediators released to systemic for proinflamatory cascade recovery till homeostatic reached.

  • If systemic pro inflamatory respon is severe or if anti inflamatory respon as its compensa- ted isnt adequate, caused pro inflamatory respon regulation failed. In this condition, found SIRS signs,then start to threat organ dysfunction.- On the opposite, if anti inflamatory respon predo-minant, caused anergy & immunosupressi, this condition named Compensatory Antiinflamatory Respose Syndrome (CARS).- The progress of life depend on reachment of ho-meostatic.If failed, last phase patogenic process, immunological dissonance happened, imbalance pro & anti inflamatory process --- clinically find MOF signs

  • InsultT,B cell,NK cell, macrophagePro inflamatory response: IL-1,IL-6,TNF-Anti inflamatory response:IL-4,IL-10,IL-13 into systemic sirculationHyperinflammatory conditionHypoinflammatory conditionSIRS Systemic Inflammatory Response SyndromeCARS (Compensatory AntiinflammatoryResponse Syndrome)Cardiovascular compromised/syok,apoptosisImmunocompromisedLost of homeostaticMODS

  • MANAGEMENTPREVENTIONWell technical surgery is important,cause from research 40% MODS case caused of surgical error.NosocomialInfection increase twice mortality.Hand washing, isolationroom, silicon iv cathetherization can reduce MODS insidence.CAUSE CONTROLThe importance thing: remove presipitate factor & cause orinfection source.SURGERYInclude bone fracture fixation,burn debridement,ischemic/ ne-crotic bowel resection,pus removal.Source of inflamatory res-ponse not always clear,sometimes surgical exploration need, especially suspicious intra abdominal source.

  • ANTIBIOTICSMaximal effort to find patogen cause infection,includeblood &body liquid culture, serology examination & aspi-ration percutan. Giving appropriate antibiotic in early processof infection disease will improve prognostic, prevent se-condary infection, nosocomial disease, then reduce MODSinsidence.

    SUPPORTIVE MANAGEMENTIf cant find spesific cause:Deficit must be correctedSupport system/organ which suffer dysfunctionGuard safety system/organ which still functionning

  • INOVATIVE THERAPYImmune ModulationBig scale research, monoclonal antibody givento manipulate immune system (magic bullets)--still notshow decrease of mortality MODS patientNO inhibitorResearch prove NOS (nitric oxide synthase) inhibitor Increase mortality.In the future, selective inhibitor toINOS (Inducible Nitric Oxide synthase) has role inmanagement MODSBLOOD FILTRATION ---still not succedHigh volume hemofiltration (2 6 filtration/h) mayfiltrate cytocines & others inflamatory mediators

  • CorticosteroidHigh dose CS (metilprednisolon 30 mg/kg) significantly increase mortality septic syok.Research in physiologic dose, show organ dysfunc-tion & syok recovery, suggest mechanism : 1.Anti inflamation by supression of proinflamatory cytocines transcription.2. Replacement therapy in cortex adrenal insufficiency3. Improve cathecolamine receptor sensitivity

    Manipulation of coagulation cascade Research of the advantages of activated protein C & antithrombin III